유럽 ​​굴절수술 장비 시장 – 2029년까지의 산업 동향 및 예측

시장 정의 및 통찰력

굴절 수술 장치는 근시(myopia), 원시(hyperopia), 노안 또는 난시와 같은 굴절 이상을 개선하거나 교정하는 데 사용됩니다. 이러한 장치에는 엑시머 레이저, YAG 레이저, 마이크로케라톰 및 펨토초 레이저가 포함됩니다. 굴절 수술은 안경이나 콘택트 렌즈에 대한 의존도를 크게 줄입니다. 다양한 굴절 장치가 시중에 시력 결함을 치료하는 데 사용됩니다.

굴절 이상은 각막이나 안구의 부적절한 모양으로 인해 발생합니다. 굴절 수술 절차에는 고급 레이저, LASIK 치료, 광굴절 각막 절제술 및 파킥 인공 수정체 및 토릭 인공 수정체와 같은 다양한 렌즈와 같은 다양한 굴절 수술 장치를 사용하여 안구나 각막을 재형성하는 것이 포함됩니다.

굴절 수술 기기 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 7.6%의 CAGR로 성장하고 있으며 2021년의 4억 2,298만 달러에서 2029년까지 7억 4,640만 달러에 도달할 것으로 분석합니다.

The Market Dynamics of the Refractive Surgery Devices Market include

Drivers

• Increase in technological advancement

Acceleration in technology development in the healthcare sector has tremendously increased in the last few years. Advancement in the technology of refractive surgery devices supports painless and uncomplicated treatment during the management of a disease. Moreover, innovation and up gradation in various refractive surgery devices assist in a precise and rapid result of disease diagnosis. Innovation in refractive surgery devices also provides the cost-effectiveness of technology-based therapeutic tools during disease treatment.

For instance,

• As per Contoura Vision India, it is found that Contoura vision surgery is the latest advanced eye surgery in the removal of specs. It is one of the safest technological advancements in eye surgery, which not only corrects the power of the spectacles but also works for corneal irregularities
• According to the Eye and Laser Centre Organisation, in May 2017, it was found that Visumax Femtosecond Laser technology is one of the most advanced refractive surgical treatments. It is capable of performing visual defects of the eyes

The increased technological advancements in various refractive surgery devices, such as advancements in lasers variable spot scanning, are expected to drive the refractive surgery devices market. Hence, growing innovation and technological advancement in refractive surgery devices are expected to bolster the market growth during the forecast period.

• Rise in healthcare expenditure

Over the last decade, healthcare expenditure has risen drastically for better patient healthcare service. The U.S. is the largest healthcare market, where the total health expenditure has increased drastically in the last few years. The fundamental purpose behind growing expenditure is to provide appropriate, affordable, and high-quality refractive surgery devices. To promote a healthier population and address the healthcare emergencies in developed and developing countries, respective government bodies and healthcare organizations are taking the initiative under accelerating healthcare expenditure.

For instance,

• According to the Health Affairs Organisation, U.S. health care spending has increased 9.7% to reach USD 4.1 trillion in 2020, which is a much faster rate than that seen in 2019
• According to the U.K. government, in 2020, the government have provided nearly GBP 250 million, which is about USD 300 million, to digitalize and advance diagnostics care across the NHS (National Health Service) using the latest technology. This funding has been allocated specifically for technological improvements to the NHS diagnostic services to detect and begin treating health conditions as early as possible
• The National Free Diagnostic Service Initiative has been rolled out as part of the National Health Mission by the Government of India. This was important to provide comprehensive and quality healthcare free of cost under one roof. With this initiative by the Indian government, several states have attempted several models to ensure the availability of diagnostics in public health facilities

Growing healthcare expenditure is also beneficial for further economic growth as well as healthcare sector growth. It significantly affects the development of new diagnostic tests and new surgical tools. Hence, huge health care expenditure is a favorable factor for the market's growth.

Opportunity

• Achievements in LASIK surgeries

The LASIK success rate or LASIK outcomes are well understood, with thousands of clinical studies looking at visual acuity and patient satisfaction. Recent research reported 99 percent of patients achieve better than 20/40 vision, and more than 90 percent achieve 20/20 or better. Furthermore, LASIK has an unprecedented 96 percent patient satisfaction rate, the highest of any elective procedure.

For instance,

• A 2016 study in the Journal of Cataract & Refractive Surgery found that LASIK has a 96% patient satisfaction rate

As per the article, "LASIK: Know the Rewards and the Risks," 2018

• Eric Donnenfeld, MD, a former president of the American Society of Cataract and Refractive Surgery, completed around 85,000 procedures over his 28-year career
• According to Market Scope, around 10 million Americans have had LASIK surgery since the FDA first approved it in 1999. Around 700,000 LASIK surgeries are done each year, but that's down from a peak of 1.4 million in 2000

Henceforth, the rising number of successful LASIK surgeries worldwide is positively associated with product development, product registration, and product launch. Thus, this is expected to drive the refractive surgery devices market in the coming years.

• Strategic initiatives by market players

An increase in the burden of refractive errors across the world have created more demand for the refractive surgery devices market. The main aim is to improve health management with the development of innovative products and surgery types for quality care with the convenient application. The key players in the refractive surgery devices market have taken strategic initiatives, which include product launches, acquisitions, and many more, and are expected to lead and create more opportunities in the refractive surgery devices market.

For instances,

• In June 2021, Glaukos Corporation received regulatory approval from the Therapeutic Goods Administration (TGA) of Australia for PRESERFLO MicroShunt. PRESERFLO MicroShunt aimed to lessen intraocular pressure (IOP) in the eyes of patients with primary open-angle glaucoma where IOP would remain uncontrollable along with being the maximum tolerated medical therapy and/or where glaucoma progression requires surgery
• In June 2021: Bausch & Lomb Incorporated signed an agreement with Lochan, a company in the Information Technology Services Industry. These companies aimed to develop the next generation of Bausch & Lomb Incorporated's eyeTELLIGENCE clinical decision support software. By utilizing the prevailing cloud-based infrastructure of eyeTELLIGENCE, this software would be developed to allow surgeons to effortlessly combine all factors of the cataract, retinal, and refractive surgery procedures to boost their total practice efficiency
• In March 2021, NIDEK unveiled RT-6100 CB for Windows, optional control software for the RT-6100 Intelligent Refractor, and the TS-610 Tabletop Refraction System. This software attunes to the distinct requirements of patients and operators. Moreover, the software enables refractions, which fulfill social distancing requirements

These many strategic products launched and acquisitions by major companies in the refractive surgery devices market have opened up an opportunity for companies worldwide. These strategies are allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is the golden opportunity for the market players to accelerate their revenue growth in the market.

Challenges/Restraints

• Lack of awareness and people trust regarding the benefits of the procedure

In many countries, the general population is not aware of refractive surgery or its various benefits for refractive errors such as myopia astigmatism, presbyopia, and others. People are scared of surgeries that it will lead to some serious side effects which are expected to give a market a great challenge.

For instance,

• According to the study by the National Institute of Health (NIH) 2021, it stated that people refused to undergo surgery because they were worried about its complications and lacked information regarding the procedure. Moreover, the study showed that 82.5% of participants were unaware that refractive surgery could enhance their visual acuity due to the lack of awareness
• According to the study by the International Journal of Medicine in Developing Countries in 2019, it was stated that-
• 32.2% of the total participants thought that refractive surgery was dangerous and 9.5% thought that it causes advanced complications
• Also, the study from India showed that 64% of participants did not know that refractive surgery was able to improve their vision

The lack of awareness regarding the benefits of refractive surgery and people's fear of surgery complications is expected to create a great challenge for the market growth.

• Lack of healthcare facilities for eye treatment

The poverty-stricken population in low- and middle-income countries suffer more from blindness and ophthalmic disorders than the wealthier population. The advancement and strategic plans taken in developed countries are not equally initiated in low-income countries. Many low-income countries usually rely on community health workers, physician assistants, and cataract surgeons for their initial primary eye care. Ophthalmology in low-income countries (LIC) is very challenging due to its complexities such as tropical climates, frail electric grids, poor road and water infrastructure, limited diagnostic capability, and limited treatment options.

For instance,

• As per the article, "Innovative Diagnostic Tools for Ophthalmology in Low-Income Countries," the 2020 report states that the prevalence of blindness and ocular disorders in high-income countries is 0.3 per 1,000 people, but in low-income countries, the estimation is 1.5 per 1,000. This shows the unmet need for ophthalmology care in low-income countries

Another major problem in low-income countries is the lack of awareness among people regarding ocular pain and other disorders. Many research studies report the high requirement of low-income countries for eye health care, and their unmet needs are still gaining attention among many health care organizations.

For instance,

• In 2014, the British Journal of Ophthalmology reported that the vision 2020 plan initiated by the government is still far from achieved due to the lack of initiatives taken targeting middle and low-income countries

Hence, the poor healthcare facility for eye treatments in low and middle-income countries are considered the greatest challenge to the growth of the refractive surgery devices market.

Post COVID-19 Impact on Refractive Surgery Devices Market

The COVID-19 has affected the market. Lockdowns and isolation during pandemics restricted the movement of the masses. As a result surgeries date and times were delayed. Hence, the pandemic has negatively affected this market

Recent Development

• In July 2021, Johnson & Johnson Vision launched the VERITAS Vision System, next-generation phacoemulsification (phaco) system. This system is developed to look after three important areas: surgeon efficiency, patient safety, and comfort. This has increased the company's product portfolio

Refractive Surgery Devices Market Scope

The refractive surgery devices market is segmented into product type, surgery type, application, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

• Laser
• Phakic Intraocular Lens (IOL)
• Aberrometers / Wavefront Aberrometry
• Surgical Instruments & Accessories
• Refractive Surgery Kits
• Pupillary Diameter Meters
• Epikeratomes
• Microkeratomes 
• Thermokeratoplasty
• Limbal Relaxing Incision Kits
• Others

On the basis of product type, the refractive surgery devices market is segmented into a laser, phakic intraocular lens (IOL), aberrometer/wavefront aberrometry, surgical instruments & accessories, refractive surgery kits, pupillary diameter meters, epikeratomes, microkeratomes, thermokeratoplasty, limbal relaxing incision kits, and others.

Surgery Type

• Lasik (Laser In-Situ Keratomileusis)
• Photorefractive Keratectomy (PRK)
• Phakic Intraocular Lenses (IOL)
• Astigmatic Keratotomy (AK)
• Automated Lamellar Keratoplasty (ALK)
• Intracorneal Ring (INTACS)
• Laser Thermal Keratoplasty (LTK)
• Conductive Keratoplasty (CK)
• Radial Keratotomy (RK)
• Others

On the basis of surgery type, the refractive surgery devices market is segmented into LASIK (laser in-situ keratomileusis), photorefractive keratectomy (PRK), phakic intraocular lenses (IOL), astigmatic keratotomy (AK), automated lamellar keratoplasty (ALK), intracorneal ring (INTACS), laser thermal keratoplasty (LTK), conductive keratoplasty (CK), radial keratotomy (RK), and others.

Application

• Nearsightedness (Myopia)
• Farsightedness (Hyperopia)
• Astigmatism
• Presbyopia

On the basis of application, the refractive surgery devices market is segmented into nearsightedness (myopia), farsightedness (hyperopia), astigmatism, and presbyopia.

End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

On the basis of end user, the refractive surgery devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others.

Distribution Channel

• Direct Tender
• Third Party Distributors
• Others

굴절수술기기 시장은 유통 채널을 기준으로 직접 입찰, 제3자 유통업체 및 기타로 구분됩니다.

굴절 수술 장치 시장 지역 분석/통찰력 

굴절 수술 장치 시장을 분석하고, 위에 언급된 대로 국가, 제품 유형, 수술 유형, 응용 분야, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

굴절 수술 장치 시장 보고서에서 다루는 국가는 독일, 프랑스, ​​영국, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 벨기에, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 기타 유럽 국가입니다.

독일은 최소 침습 수술의 채택이 증가함에 따라 시장을 장악할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 굴절 수술 장비 시장 점유율 분석

굴절 수술 기기 시장 경쟁 구도는 경쟁자에 의한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 회사가 굴절 수술 기기 시장에 집중하는 것과만 관련이 있습니다.

굴절 수술 장치 시장을 다루는 주요 기업으로는 Tracey Technologies, Bausch + Lomb Incorporated, BD, STAAR SURGICAL, SCHWIND eye-tech-solutions, Hoya Surgical Optics, Johnson & Johnson Services, Inc., Ophtec BV, Glaukos Corporation, Amplitude Laser, Reichert, Inc., NIDEK CO., LTD., Ziemer Ophthalmic Systems, ROWIAK GmbH, Moria, LENSAR, Inc., Topcon Canada Inc. (Topcon Corporation의 자회사), Aaren Scientific Inc., Rayner Intraocular Lenses Limited., iVIS Technologies, Alcon 등이 있습니다.

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 것을 자랑으로 생각합니다. 보고서는 타겟 브랜드의 가격 추세 분석, 추가 국가 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 타겟 경쟁업체의 시장 분석은 기술 기반 분석에서 시장 포트폴리오 전략까지 분석할 수 있습니다. 필요한 만큼 많은 경쟁업체를 원하는 형식과 데이터 스타일로 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 Excel 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용할 수 있는 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

SKU-52810